Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Storch

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|June 6, 2000
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North AmericaT C Peret, C B Hall, G W Hammond, et al.
Journal of Clinical Microbiology|September 1, 1997
Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCRT C Roberts, R S Buller, M Gaudreault-Keener, et al.
The American Review of Respiratory Disease|April 1, 1993
Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant GroupN A Ettinger, T C Bailey, E P Trulock, et al.
Journal of Clinical Microbiology|October 30, 2001
Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assayA A Gusa, R S Buller, G A Storch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
The Journal of Infectious Diseases|September 5, 1998
Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipientsT C Roberts, D C Brennan, R S Buller, et al.
The Journal of Infectious Diseases|April 1, 1995
Quantitative analysis of cytomegalovirus viremia in lung transplant recipientsT C Bailey, R S Buller, N A Ettinger, et al.
Transplantation Proceedings|February 1, 1997
Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patientsD C Brennan, K A Garlock, B J Lippmann, et al.
Journal of the American Society of Nephrology : JASN|January 1, 1997
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapyD C Brennan, K A Garlock, B A Lippmann, et al.
The Journal of Infectious Diseases|March 1, 1990
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipientsL Marsano, R P Perrillo, M W Flye, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|June 6, 2000
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North AmericaT C Peret, C B Hall, G W Hammond, et al.
Journal of Clinical Microbiology|September 1, 1997
Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCRT C Roberts, R S Buller, M Gaudreault-Keener, et al.
The American Review of Respiratory Disease|April 1, 1993
Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant GroupN A Ettinger, T C Bailey, E P Trulock, et al.
Journal of Clinical Microbiology|October 30, 2001
Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assayA A Gusa, R S Buller, G A Storch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
The Journal of Infectious Diseases|September 5, 1998
Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipientsT C Roberts, D C Brennan, R S Buller, et al.
The Journal of Infectious Diseases|April 1, 1995
Quantitative analysis of cytomegalovirus viremia in lung transplant recipientsT C Bailey, R S Buller, N A Ettinger, et al.
Transplantation Proceedings|February 1, 1997
Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patientsD C Brennan, K A Garlock, B J Lippmann, et al.
Journal of the American Society of Nephrology : JASN|January 1, 1997
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapyD C Brennan, K A Garlock, B A Lippmann, et al.
The Journal of Infectious Diseases|March 1, 1990
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipientsL Marsano, R P Perrillo, M W Flye, et al.
Pageof 10